Compare Abbott Laboratories (ABT) vs Kaltura Inc (KLTR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Kaltura Inc — how do they compare? Abbott Laboratories trades at $95.4 (market cap $166.94B), while Kaltura Inc trades at $1.25 (market cap $193.23M). The key difference: Abbott Laboratories is far larger — about 863.9× Kaltura Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Kaltura Inc pays none. Which is the better fit depends on your goals.
| ABT | KLTR | |
|---|---|---|
Market Cap | $166.94B | $193.23M |
Sector | Health | Technology |
52-Week High | $136.62 | $2.01 |
52-Week Low | $82.57 | $1.08 |
Enterprise Value | $193.69B | $175.95M |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Kaltura (KLTR) trades at $1.29, up 2.38% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with revenue stabilizing around $180M and narrowing losses, though it remains unprofitable with negative margins. Recent industry recognition and AI product launches highlight strategic positioning in digital experience platforms.
Investment outlook balances operational improvements against persistent profitability challenges. Positive analyst sentiment (44% buy ratings) and strong institutional coverage suggest potential upside if AI initiatives drive growth, but high P/B ratio and negative cash flow pose risks for near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
